Heartflow (NASDAQ:HTFL) Shares Down 10.6% – Here’s What Happened

Heartflow, Inc. (NASDAQ:HTFL) was down 10.6% during trading on Thursday . The stock traded as low as $31.94 and last traded at $31.94. Approximately 74,635 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 404,881 shares. The stock had previously closed at $35.74.

Wall Street Analyst Weigh In

A number of analysts have recently commented on HTFL shares. Canaccord Genuity Group boosted their target price on shares of Heartflow from $35.00 to $39.00 and gave the stock a “buy” rating in a research note on Monday, September 22nd. Stifel Nicolaus initiated coverage on Heartflow in a research note on Tuesday, September 2nd. They set a “buy” rating and a $35.00 price objective for the company. Piper Sandler began coverage on Heartflow in a research report on Tuesday, September 2nd. They issued an “overweight” rating and a $38.00 target price on the stock. Weiss Ratings initiated coverage on Heartflow in a research note on Saturday, November 1st. They issued a “sell (d+)” rating for the company. Finally, JPMorgan Chase & Co. assumed coverage on Heartflow in a report on Tuesday, September 2nd. They issued an “overweight” rating and a $36.00 price objective on the stock. Four research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Heartflow has an average rating of “Hold” and an average target price of $36.60.

Heartflow Stock Performance

The stock has a 50 day moving average price of $34.73.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings data on Friday, September 19th. The company reported ($1.46) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($1.26). The firm had revenue of $43.42 million during the quarter, compared to analyst estimates of $43.20 million.

Institutional Trading of Heartflow

Large investors have recently bought and sold shares of the business. JPMorgan Chase & Co. purchased a new stake in shares of Heartflow in the third quarter valued at about $13,887,000. Vanguard Group Inc. acquired a new position in shares of Heartflow during the 3rd quarter worth $48,871,000. TFC Financial Management Inc. acquired a new stake in shares of Heartflow in the 3rd quarter worth approximately $40,000. Baillie Gifford & Co. acquired a new stake in shares of Heartflow in the third quarter valued at approximately $101,182,000. Finally, Board of Trustees of The Leland Stanford Junior University purchased a new position in shares of Heartflow during the 3rd quarter worth $10,510,000.

About Heartflow

We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.